Back to Journals » Therapeutics and Clinical Risk Management » Volume 12

New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
14,322 | Dovepress* | 12,147 | 1,135+ | 1,746 | 13,282 |
PubMed Central* | 0 | 1,040 | 326 | 1,040 | |
Totals | 12,147 | 2,175 | 2,072 | 14,322 | |
*Since 5 May 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
18 | 0 | 0 | 1 | 8 | 9 |
View citations on PubMed Central and Google Scholar